Eucrates Biomedical
Why Robinhood?
You can watch EUCR and buy or sell other stocks, ETFs, and their options commission-free!About EUCR
Eucrates Biomedical Acquisition Corp. operates as a blank Check company focusing on acquiring, engaging in a share exchange, share reconstruction and amalgamations. The company was founded by Stelios Papadopoulos, Parag Saxena, Evangelos Vergetis and Daphne Karydas on August 21, 2020 and is headquartered in New York, NY.
EUCR Key Statistics
Stock Snapshot
The current Eucrates Biomedical(EUCR) stock price is $10.04, with a market capitalization of 42.23M. The stock trades at a price-to-earnings (P/E) ratio of 53.46.
Eucrates Biomedical(EUCR) stock opened on 2026-10-10 at —. The price climbed to — and dipped to —.
The Eucrates Biomedical(EUCR)'s current trading volume is 0, compared to an average daily volume of 7.18K.
In the last year, Eucrates Biomedical(EUCR) shares hit a 52-week high of $10.25 and a 52-week low of $9.87.
In the last year, Eucrates Biomedical(EUCR) shares hit a 52-week high of $10.25 and a 52-week low of $9.87.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.